While the oestrogen protective effects in CRC have been mainly attributed to ERβ, its expression is lost during CRC progression, and this raises the possibility for a role in sex differences of GPER, which remains expressed after ERβ loss in CRC [178]. The gene discussed is GPER1; the disease is colorectal carcinoma.